Martingale Asset Management L P Shattuck Labs, Inc. Transaction History

Martingale Asset Management L P

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$2.7 - $4.59 $21 - $36	-8 Reduced 0.02%	36,990 $150,000
Q1 2022 May 12, 2022	BUY	$4.22 - $8.89 $58,835 - $123,944	13,942 Added 60.47%	36,998 $157,000
Q4 2021 Feb 11, 2022	BUY	$8.36 - $21.08 $192,748 - $486,020	23,056 New	23,056 $196,000

28.8M

300

1.2K

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $46.6M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.